CN106924463A - Treat the Chinese medicine of apoplexy - Google Patents

Treat the Chinese medicine of apoplexy Download PDF

Info

Publication number
CN106924463A
CN106924463A CN201710247120.5A CN201710247120A CN106924463A CN 106924463 A CN106924463 A CN 106924463A CN 201710247120 A CN201710247120 A CN 201710247120A CN 106924463 A CN106924463 A CN 106924463A
Authority
CN
China
Prior art keywords
parts
chinese medicine
apoplexy
radix
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710247120.5A
Other languages
Chinese (zh)
Inventor
肖志远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710247120.5A priority Critical patent/CN106924463A/en
Publication of CN106924463A publication Critical patent/CN106924463A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a kind of Chinese medicine for treating apoplexy, by the fleece-flower root, cassia seed, Ligusticum wallichii, Ramulus Taxilli, pseudo-ginseng, rhizoma alismatis, giant knotweed, granatum, semen armeniacae amarae, the fruit of Chinese wolfberry, the red sage root, Radix Glycyrrhizae, the Radix Astragali, the radix paeoniae rubrathe, earthworm, the bighead atractylodes rhizome, lotus seeds, Radix Angelicae Sinensis, schizonepeta；Raw material of the invention is conventional Chinese herbal medicine, wide material sources are cheap, pharmaceutical formulation is scientific and reasonable, acted synergistically between each component, with nourishing and suppressing Yang, blood circulation and channel invigorating, to being contained in the deficiency of liver-yin and kidney-yin, the phlegm wet of hyperlipidemia, disappear the specific therapeutic action of fat with harmonizing the liver and spleen, dampness elimination, dizzy, abdominal distension is intended to tell, limb fiber crops body weight, loose stool are not well, complexion it is dim it is stagnant, full vexed, heart pain uncomfortable in chest, sleepy thermophilic sleeping, shortness of breath palpitations, forgetful god is slow-witted in the heart, soreness of waist salivation has significant curative effect.The present invention is applied to treatment apoplexy.

Description

Treat the Chinese medicine of apoplexy
Technical field
The invention belongs to key areas, it is related to a kind of Chinese medicine for treating apoplexy.
Background technology
Apoplexy, names of disease of tcm, have exogenous wind and interior wind point, exogenous wind is because of being invaded by exogenous pathogen,invasion of exogenous pathogen（Ailment said due to cold or exposure）It is caused,《The Treatise on Fevrile Diseases》Name Say apoplexy（Also known as syndrome of decoction GUI ZHI）；Interior wind belongs to diseases caused by internal damage, also known as cerebral apoplexy, palsy etc..Modern times are commonly referred to as apoplexy, refer to internal injury more The apoplectic stroke of disease, more because qi and blood is inverse disorderly, the resistance of brain vessle-Bi symptom-complex or blood are overflow caused by brain.With unexpected dusk servant, hemiplegia, limbs fiber crops Wood, tongue are not smoothgoing in silence, and dispute is crooked, and hemianesthesia etc. is the brain disease of main performance.And, such as wind fast with onset urgency, change The disease of the feature of evil benefaction number change.
Because Apoplexy Morbidity is high, the death rate is high, disability rate is high, high recurrence rate and the characteristics of many complication, so doctor Educational circles is listed as its same coronary heart disease, cancer to threaten one of three big diseases of human health.This cause of disease is more, from terms of clinic, With internal cause, occasioner is in the majority.The generation of apoplexy, is summed up not outer void, fire, wind, phlegm, gas, the end of blood six.
1, feelings will is disgruntled：Five excessive emotional activities, internal heat cruelly very, can in priming wind and send out palsy.Clinic with the violent rage impariment of the liver be it is many, Because violent rage then extreme hyperactivity of the liver-yang in no time, gas fire are all floating, compel to be gushed on blood, its time must be sent out.Fear as troubled thoughts compassion, it is nervous equal It is this sick inducement；
2, eating and drinking without temperance：Overfeeding delicious food pure wine, the dysfunction of the spleen in transport, accumulatively wet raise phlegm, stagnation of phlegm converting into heat, priming liver wind is disturbed on folder phlegm, can Cause a disease hair, induces most strong to indulge in excessive drinking especially；
3, overwork《：Plain Questions vitality of human communicating and corresponding to the universe is discussed》Say：" yang-energy person, bothers, and opens ", that is, refer to personal yang-energy, if disturbance is too Cross, then it is excited not hold back；This disease also can be because managing excessively, and body and the spirit is lost and supported, so that the moon blood secretly consumes, empty sun wind transmission disturbance is trouble.Moreover Wound of indulging in sensual pleasures essence, is also that water is lost under, hyperactivity of fire in upper, morbidity because；
4, climate changes：This disease can occur throughout the year, but relevant with seasonal climate change；Enter the winter turns cold suddenly, cold-evil Invasion, can influence blood vessels circulation.As《Plain Questions menstruation regulating opinion》Say " cold solely to stay, then blood clotting, solidifying then arteries and veins is obstructed ... "；Its When secondary early spring turns warm suddenly, on the occasion of the chilly wind main order of wood of fainting, in liver, wind sun is dark dynamic, may also lead to the generation of this disease for planted agent；
The 5, blood stasis of bloods are stagnant：The formation of blood stasis is more because stagnation of the circulation of vital energy hematogenous blockage or deficiency of vital energy fortune blood are powerless, or because violent rage blood accumulates in upper, or Because the cold spasm of sense stagnates, or because the impairment of yin liquid hematozemia of heat is stagnant etc., this sick interpretation of the cause, onset and process of an illness is more to be accumulate or qi deficiency to blood stasis is the most normal with violent rage blood See.
The traditional Chinese medical science thinks apoplexy often because body is first empty, and negative and positive lose balance, and qi and blood is inverse disorderly, and phlegm-blood stasis retardance, limbs are lost caused by supporting. Phlegm-blood stasis are this sick major pathogenetic factor, and phlegm-blood stasis block train of thought and cause limbs to be unable to voltuntary movement, and then suffering limb is skinny long, numb It is meciless.
The content of the invention
The technical problems to be solved by the invention are intended to provide a kind of Chinese medicine for treating apoplexy, and the drug matching is reasonable, Acted synergistically between each component, with nourishing and suppressing Yang, blood circulation and channel invigorating, to being contained in the deficiency of liver-yin and kidney-yin, the phlegm wet of hyperlipidemia, and conditioning Liver spleen, dampness elimination disappear the specific therapeutic action of fat, dizzy, abdominal distension are intended to tell, limb fiber crops body weight, loose stool are not well, complexion is dim It is stagnant, full vexed, heart pain uncomfortable in chest, sleepy thermophilic sleeping, shortness of breath palpitations, forgetful god is slow-witted in the heart, soreness of waist salivation has significant curative effect.
In order to solve the above technical problems, the technical solution adopted by the present invention is as follows：
A kind of Chinese medicine for treating apoplexy, in parts by weight, it includes following component：
30 parts of the fleece-flower root, 20 parts of cassia seed, 20 parts of the fruit of Chinese wolfberry, 15 parts of Ligusticum wallichii, 15 parts of Ramulus Taxilli, 15 parts of pseudo-ginseng, 15 parts of rhizoma alismatis, tiger It is 15 parts of cane, 10 parts of granatum, 10 parts of semen armeniacae amarae, 10 parts of the red sage root, 10 parts of Radix Glycyrrhizae, 15 parts of the Radix Astragali, 15 parts of the radix paeoniae rubrathe, 10 parts of earthworm, white 10 parts of art, 10 parts of lotus seeds, 10 parts of Radix Angelicae Sinensis, 10 parts of schizonepeta.
Present invention also offers the preparation method of the Chinese medicine of above-mentioned treatment apoplexy, above-mentioned Chinese medicine material is soaked in three times 2h in the clear water of medicine raw material weight, is then placed on after big fire in frying pan boils, and turns small fire and decocts 40min.
The usage and dosage of above-mentioned Chinese medicine：Take 150 milliliters of Chinese medicine liquid every time, it is sooner or later each once, one hour before meals or after meal two Hour takes.The course for the treatment of：10d is a course for the treatment of, need to be taken medicine continuously with the 6-10 course for the treatment of.
Beneficial effects of the present invention：The Chinese medicine of the treatment apoplexy that the present invention is provided, compatibility is reasonable, all medicines share, with treatment Effect significantly, safe ready, it is cheap the characteristics of, the Chinese medicine has nourishing and suppressing Yang, blood circulation and channel invigorating, to the deficiency of liver-yin and kidney-yin, hyperlipemia Contained in the phlegm wet of disease, and harmonizing the liver and spleen, dampness elimination disappear the specific therapeutic action of fat, dizzy, abdominal distension is intended to tell, limb fiber crops body Weight, loose stool is not well, complexion it is dim it is stagnant, full vexed, heart pain uncomfortable in chest, sleepy thermophilic sleeping, shortness of breath palpitations, forgetful god is slow-witted in the heart, soreness of waist salivation has Significant curative effect.
The present invention is applied to treatment apoplexy.
Specific embodiment
A kind of Chinese medicine for treating apoplexy of embodiment 1
A kind of Chinese medicine for treating apoplexy is present embodiments provided, it includes following component：
Fleece-flower root 30g, the g of cassia seed 20, the g of the fruit of Chinese wolfberry 20, the g of Ligusticum wallichii 15, the g of Ramulus Taxilli 15, the g of pseudo-ginseng 15, the g of rhizoma alismatis 15, tiger It is the g of cane 15, the g of granatum 10, the g of semen armeniacae amarae 10, the g of the red sage root 10, the g of Radix Glycyrrhizae 10, the g of the Radix Astragali 15, the g of the radix paeoniae rubrathe 15, the g of earthworm 10, white The g of art 10, the g of lotus seeds 10, the g of Radix Angelicae Sinensis 10, the g of schizonepeta 10.
The preparation method of the Chinese medicine of above-mentioned treatment apoplexy, the clear of three times Chinese medicine material weight is soaked in by above-mentioned Chinese medicine material 2h in water, is then placed on after big fire in frying pan boils, and turns small fire and decocts 40min.
The usage and dosage of Chinese medicine：150 milliliters of Chinese medicine liquid, sooner or later respectively once, one hour before meals or two hours after meal are taken every time Take.The course for the treatment of：10d is a course for the treatment of, need to be taken medicine continuously with the 6-10 course for the treatment of.
Toxicity test:
（1）Test drug：It is the Chinese medicine in the embodiment of the present invention 1.
（2）Experimental animal：IcR kind small white mouses, body weight 20-25g, male-female half and half, totally 40.
（3）Test method：After fasting 15h, by daily 20ml to mice lavage 3 months, long term toxicity test result shows It is shown as, small white mouse body weight, liver function, renal function, blood picture etc. and control group no significant difference show the safety of the medicine, belong to nothing Malicious rank.
The clinical case of embodiment 2
First, data and method
1. physical data：200 paralytics, the age at 37-74 Sui, average age 57 years old, wherein male 103, women 97 Example；At the age, the aspect such as the state of an illness, course of disease is statistically analyzed all patients, no significant difference（The .05 of P ＞ 0）, tool There is comparativity.
2. diagnostic criteria
Primary symptom：Hemiplegia, god knows dusk and covers, sluggish speech or in silence, and hemiparesthesia, dispute is crooked.
Secondary disease：Headache, dizziness, pupil god's change, drinking-water hair are choked, mesh not wink, incoordination partially.
Acute onset, has inducement premorbid more, often there is premonitory symptom.Age of onset is more more than 43 years old.
Possess more than 2 primary symptoms, or 1 primary symptom 2 time disease, can be made a definite diagnosis with reference to onset, inducement, premonitory symptom, age； Do not possess above-mentioned condition, can also be made a definite diagnosis with reference to imageological examination result.
3. treatment method
All patients are randomly divided into experimental group and each 100 of control group, and experimental group is taken during the embodiment of the present invention 1 provided Medicine, instructions of taking and consumption take Angong Niuhuang Wan, instructions of taking and consumption according to the data provided in embodiment 1, control group According to the data provided in embodiment 1.6 courses for the treatment of of common observation and treatment.
4. curative effect determinate standard
Cure：Clinical symptoms and sign are all disappeared, and laboratory examination is returned to normal；
It is effective：Symptomatology is eliminated or cardinal symptom is eliminated, and laboratory examination is significantly improved；
Effectively：Clinical symptoms are substantially eliminated, and laboratory examination has improvement；
It is invalid：Clinical symptoms and sign it is unchanged or relatively treat before aggravate.
Total effective rate=（Cure number of cases+effective number of cases+effective number of cases）∕ total inspection case load × 100%.
5. treatment results
Two groups for the treatment of results of patient：Experimental group cures 91, effective 6, effective 2, invalid 1, total effective rate 99%；It is right Cure 50, effective 16, effective 3, invalid 31, total effective rate 69% according to group.
From result, experimental group therapeutic effect is substantially better than control group.
Model case
Case 1：Shen, female 58 years old, suffers from headstroke for many years, and the right body is numb, powerless throughout the year, speaks and pronounces indistinctly.Using this hair The treatment by Chinese herbs that bright embodiment 1 is provided, after 3 courses for the treatment of of treatment, articulation and clear of speaking, but word speed is slower, and it is numb in every limb to have changed It is kind.3 courses for the treatment of of continuous treatment, brothers are no longer numb, can independently be careful, and articulation and clear of speaking, word speed is normal, cure.Case 2： Zhang, man, 67 years old, suffers from headstroke for many years, dysphonia, facial paralysis, through using drug therapy of the present invention, treats 2 treatments Journey, extremity numbness disappears substantially, and 3 courses for the treatment of of continual cure, extremity numbness is wholly absent, and mind is clear, articulation and clear of speaking, language Fast normal, mouth eye is no longer crooked, cures.
Above-described embodiment, is only presently preferred embodiments of the present invention, is not other forms made for the present invention Limit, any those skilled in the art are changed as enlightenment possibly also with above-mentioned technology contents or are modified as equivalent The Equivalent embodiments of change.In every case it is the technical spirit without departing from the claims in the present invention, to the letter done by above example Single modification, equivalent variations and remodeling, still fall within the scope of the claims in the present invention protection.

Claims (2)

1. a kind of Chinese medicine for treating apoplexy, it is characterised in that in parts by weight, it includes following component：
30 parts of the fleece-flower root, 20 parts of cassia seed, 20 parts of the fruit of Chinese wolfberry, 15 parts of Ligusticum wallichii, 15 parts of Ramulus Taxilli, 15 parts of pseudo-ginseng, 15 parts of rhizoma alismatis, tiger It is 15 parts of cane, 10 parts of granatum, 10 parts of semen armeniacae amarae, 10 parts of the red sage root, 10 parts of Radix Glycyrrhizae, 15 parts of the Radix Astragali, 15 parts of the radix paeoniae rubrathe, 10 parts of earthworm, white 10 parts of art, 10 parts of lotus seeds, 10 parts of Radix Angelicae Sinensis, 10 parts of schizonepeta.
2. the preparation method of the Chinese medicine of apoplexy is treated as claimed in claim 1, it is characterised in that：By the immersion of above-mentioned Chinese medicine material The 2h in the clear water of three times Chinese medicine material weight, is then placed on after big fire in frying pan boils, and turns small fire and decocts 40min.
CN201710247120.5A 2017-04-17 2017-04-17 Treat the Chinese medicine of apoplexy Withdrawn CN106924463A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710247120.5A CN106924463A (en) 2017-04-17 2017-04-17 Treat the Chinese medicine of apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710247120.5A CN106924463A (en) 2017-04-17 2017-04-17 Treat the Chinese medicine of apoplexy

Publications (1)

Publication Number Publication Date
CN106924463A true CN106924463A (en) 2017-07-07

Family

ID=59436735

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710247120.5A Withdrawn CN106924463A (en) 2017-04-17 2017-04-17 Treat the Chinese medicine of apoplexy

Country Status (1)

Country Link
CN (1) CN106924463A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492111A (en) * 2016-11-15 2017-03-15 劳冠阳 The medicine for the treatment of apoplexy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492111A (en) * 2016-11-15 2017-03-15 劳冠阳 The medicine for the treatment of apoplexy

Similar Documents

Publication Publication Date Title
CN102139086B (en) Traditional Chinese medicine for treating liver stagnation and spleen deficiency type post-stroke depression
CN103961424B (en) A kind of treat the Chinese medicine formula of cervical spondylosis and the preparation method of capsule preparations thereof
CN103989818A (en) Medicinal liquor
CN103705705A (en) Traditional Chinese medicine composition for treating polymyositis
CN101780176B (en) Traditional Chinese medicine preparation for treating nervous headache
CN115054649B (en) A Chinese medicinal composition for treating diabetic peripheral neuropathy, and its preparation method
CN107349284A (en) A kind of medicine for treating blood stasis type apoplexy
CN101564495B (en) Series medicaments for psychosis negative four-step therapy
CN106924463A (en) Treat the Chinese medicine of apoplexy
CN103495108B (en) Medicine for treating chronic hypotension and preparation method for medicine
CN105362689A (en) Traditional Chinese medicine composition for treating spleen-kidney deficiency type post-ischemic-stroke vascular dementia
CN110090260A (en) The drug for treating melosalgia diabete peripheral herve pathology
van der Sluijs et al. Traditional Chinese Medicine
CN102078539B (en) Medicines based on negative classification and four-step therapy of psychosis
CN102836241A (en) Traditional Chinese medicine combination for treating neck shoulder lumbocrural pains caused by spinal degenerative change
CN107260978A (en) A kind of Chinese medicine composition and its production and use
CN105456415A (en) Traditional Chinese medicine for preventing and treating apoplexia
CN105395640A (en) Traditional Chinese medicine preparation for preventing and treating stroke
Li et al. Professor Xiaofeng’s Zhang Experience in Treating Postpartum Body Pain
Wilson et al. Integrative approach to migraine using traditional European, Indian and Chinese medicine: a case report
CN105395641A (en) Traditional Chinese medicine composition for preventing and treating stroke
CN102078540B (en) Series medicines for psychosis negative four-step treatment
Yang et al. Introduction to Formulae of Traditional Chinese Medicine
CN109224056A (en) A kind of drug and preparation method thereof for treating gastroptosis
CN102078591B (en) Series of medicines for mental negative by using four-step treatment method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20170707

WW01 Invention patent application withdrawn after publication